Effects of chronic use of proton pump inhibitors
DOI:
https://doi.org/10.33448/rsd-v13i4.45613Keywords:
Proton pump inhibitors; Adverse effects; Signs and symptoms.Abstract
Proton pump inhibitors (PPIs) act by inhibiting the enzyme H+/K+ ATPase, significantly reducing gastric acid production and lowering stomach pH. Therefore, they are considered the first-line treatment for gastrointestinal reflux disease and Barrett's esophagus, as well as being considered in the treatment of other conditions such as H. pylori infection and eosinophilic esophagitis. They are drugs with infrequent adverse effects and easy access, as no prescription is required to acquire them. These factors contribute to their indiscriminate use and consequently the emergence of deleterious effects on human health. This study is an integrative literature review, gathering published data on the chronic effects of proton pump inhibitors. Articles published in national and international journals related to scientific research were used. Based on the identification of the problem, the thematic bases of the study were defined, and literary references that met the inclusion criteria were selected. Then, the information was synthesized. The databases used for the study were Scielo, Public Medline, and PubMed. Therefore, this literature review aims to explore various available studies on the effects of chronic use of proton pump inhibitors, with the goal of encouraging further scientific production on this topic and subsequently guiding clinical practice.
References
Aguilera-Castro, L., Martín-de-Argila-de-Prados, C., & Albillos-Martínez, A. (2016). Practical considerations in the management of proton-pump inhibitors. Rev Esp Enferm Dig, 108(3), 145-53.
Araújo, L. S., Araujo, B. M., Guimarães, C. S., Fróes, D. N. S., Maia, E. C. S., Hoffmann, G., & Leite, N. A. A. (2021). Inibidores de Bomba de Prótons: vantagens e desvantagens do uso prolongado. Revista Eletrônica Acervo Científico, 34, e8662-e8662
Ariel, H., & Cooke, J. P. (2019). Cardiovascular risk of proton pump inhibitors. Methodist DeBakey cardiovascular journal, 15(3), 214.
Cooke, J. P., anford UUniveversittyy, S., Staanfnfooord, D. C., nng GGrrooup, O. S., & SSciienccess, M. C. (2013). An Unexpected Effect of Proton Pump Inhibitors: Elevation of the Cardiovascular Risk Factor ADMA.
Costa, S. D. A. L., Marques, L. F., Aleixo, A. G., da Silva, L. F., Santos, N. V. P., de Caramalac Jr, A. R., ... & da Nóbrega Ayres, A. M. (2021). Efeitos do uso prolongado de Inibidores de Bomba de Prótons em idosos. Brazilian Journal of Health Review, 4(2), 4248-4265.
de-la-Coba, C., Argüelles-Arias, F., Martín-de-Argila, C., Júdez, J., Linares, A., Ortega-Alonso, A., ... & Giganto, F. (2016). Efectos adversos de los inhibidores de la bomba de protones: revisión de evidencias y posicionamiento de la Sociedad Española de Patología Digestiva. Revista Española de Enfermedades Digestivas, 108(4), 207-224.
Eusebi, L. H., Rabitti, S., Artesiani, M. L., Gelli, D., Montagnani, M., Zagari, R. M., & Bazzoli, F. (2017). Proton pump inhibitors: risks of long‐term use. Journal of gastroenterology and hepatology, 32(7), 1295-1302.
Ghebremariam, Y. T., LePendu, P., Lee, J. C., Erlanson, D. A., Slaviero, A., Shah, N. H., & Cooke, J. P. (2013). Unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine. Circulation, 128(8), 845-853.
Hojo, M., Asahara, T., Nagahara, A., Takeda, T., Matsumoto, K., Ueyama, H., & Watanabe, S. (2018). Gut microbiota composition before and after use of proton pump inhibitors. Digestive diseases and sciences, 63, 2940-2949.
Ivo, S. E. D., Pereira, A. M., & Soares, L. C. (2021). Uso de inibidores de bomba de prótons entre estudantes de medicina de uma instituição de ensino superior de Maringá-PR e as consequências à curto e longo prazo. Brazilian Journal of Development, 7(9), 88402-88426.
Lima, J. M. D., Dal-Fabbro, A. L., & Funayama, A. R. (2019). Uso do omeprazol: estudo descritivo de pacientes idosos de uma Unidade de Saúde da Família (USF) de Ribeirão Preto, SP, Brasil. Infarma-Ciências Farmacêuticas, 31(1), 46-53.
Markovits, N., Loebstein, R., Halkin, H., Bialik, M., Landes‐Westerman, J., Lomnicky, J., & Kurnik, D. (2014). The association of proton pump inhibitors and hypomagnesemia in the community setting. The Journal of Clinical Pharmacology, 54(8), 889-895.
Morschel, C. F., Mafra, D., & Eduardo, J. C. C. (2018). Inibidores da bomba de prótons e sua relação com a doença renal. Brazilian Journal of Nephrology, 40, 301-306.
Nochaiwong, S., Ruengorn, C., Awiphan, R., Koyratkoson, K., Chaisai, C., Noppakun, K., & Thavorn, K. (2018). The association between proton pump inhibitor use and the risk of adverse kidney outcomes: a systematic review and meta-analysis. Nephrology Dialysis Transplantation, 33(2), 331-342.
Ortiz-Guerrero, G., Amador-Muñoz, D., Calderón-Ospina, C. A., López-Fuentes, D., & Nava Mesa, M. O. (2018). Proton pump inhibitors and dementia: physiopathological mechanisms and clinical consequences. Neural plasticity, 2018.
Shin, J. M., & Kim, N. (2013). Pharmacokinetics and pharmacodynamics of the proton pump inhibitors. Journal of neurogastroenterology and motility, 19(1), 25.
Su, T., Lai, S., Lee, A., He, X., & Chen, S. (2018). Meta-analysis: proton pump inhibitors moderately increase the risk of small intestinal bacterial overgrowth. Journal of gastroenterology, 53, 27-36.
Teixeira, E., Medeiros, H. P., Nascimento, M. H. M., Costa, B. A., & Rodrigues, C. (2013). Integrative literature review step-by-step & convergences with other methods of review/Revisão Integrativa da Literatura passo-a-passo & convergências com outros métodos de revisão. Revista de Enfermagem da UFPI, 2(5), 3-7.
Trifan, A., Stanciu, C., Girleanu, I., Stoica, O. C., Singeap, A. M., Maxim, R., & Boiculese, L. (2017). Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis. World journal of gastroenterology, 23(35), 6500.
Turshudzhyan, A., Samuel, S., Tawfik, A., & Tadros, M. (2022). Rebuilding trust in proton pump inhibitor therapy. World Journal of Gastroenterology, 28(24), 2667.
Yepuri, G., Sukhovershin, R., Nazari-Shafti, T. Z., Petrascheck, M., Ghebre, Y. T., & Cooke, J. P. (2016). Proton pump inhibitors accelerate endothelial senescence. Circulation research, 118(12), e36-e42.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 José Carlos da Silva Junior; Juliana Ramos Friggi
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
